Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Central Nervous System Neoplasms 11Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Ovarian Neoplasms 3Lung Neoplasms 3Head and Neck Neoplasms 3Gliosarcoma 3Glioblastoma 3Endometrial Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Astrocytoma 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neuroblastoma 2Kidney Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Vomiting 1Urinary Bladder Neoplasms 1Tongue Neoplasms 1Teratoma 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Solitary Fibrous Tumor, Pleural 1Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1

Interventions

Tamoxifen 1Medroxyprogesterone 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Paget's Disease, Mammary × Chemotherapy, Adjuvant × Clear all
NCT00002920 2012-10-31

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed
313 enrolled
BreastGynecologic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡